Keyphrases
Israel
100%
Human Immunodeficiency Virus Type 1 (HIV-1)
44%
COVID-19
40%
BNT162b2 Vaccine
16%
Virus
15%
SARS-CoV-2 Variants
13%
HIV-1 Infection
12%
Israeli
12%
Direct-acting Antivirals
12%
Europe
12%
Hepatitis C Virus
12%
Resistance-associated Substitutions
10%
Geenius
10%
Hepatitis E Virus
10%
Immune Response
10%
Liver Transplant Recipients
10%
Men Who Have Sex with Men
10%
Vaccination
9%
HIV Infection
9%
HIV Patients
9%
Viral Load
9%
Transmitted Drug Resistance mutations
9%
Seroprevalence
9%
Quantitative PCR
9%
Genotype 1
8%
Hepatitis A
8%
Antiretroviral Therapy
8%
Tel Aviv
8%
Drug Resistance
8%
Xpert
8%
Resistance mutations
8%
HIV Drug Resistance
8%
BNT162b2
7%
Receptor-binding Domain
7%
Virology
7%
Hepatitis E
7%
Hepatitis A Virus
7%
IgG Antibody
7%
Virological Failure
7%
Viral
7%
Circulating Recombinant Form
7%
Confidence Interval
6%
Molecular Epidemiology
6%
CD4 Count
6%
Sewage Sample
6%
COVID-19 Pandemic
6%
SARS-CoV-2 Genome
6%
Fully Vaccinated
6%
Phylogenetic Analysis
6%
Treatment Failure
6%
Medicine and Dentistry
Human Immunodeficiency Virus
44%
Severe Acute Respiratory Syndrome Coronavirus 2
37%
Infection
18%
Drug Resistance
16%
Virus
12%
COVID-19
11%
Hepatitis A Virus
10%
Prevalence
9%
Resistance Mutation
9%
Men Who Have Sex with Men
8%
Neutralization
8%
Human Immunodeficiency Virus 1 Infection
8%
Cohort Effect
7%
Antiviral Drug
7%
Human Immunodeficiency Virus Infection
7%
Hepatitis C Virus
6%
Diseases
6%
Antiretroviral Therapy
6%
Retrospective Cohort Study
6%
Coronavirinae
5%
Virus Infection
5%
Antivirus Agent
5%
Public Health
5%
Transitional Cell Carcinoma
5%
Acute Hepatitis
5%
Tumor Antigen
5%